Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review

被引:9
|
作者
Wright, Stuart J. [1 ]
Newman, William G. [2 ,3 ]
Payne, Katherine [1 ]
机构
[1] Univ Manchester, Manchester Ctr Hlth Econ, Div Populat Hlth Hlth Serv Res & Primary Care, Oxford Rd, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Div Evolut & Genom Sci, Manchester Ctr Genom Med, Manchester, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, North West Genom Lab Hub, Manchester, Lancs, England
基金
英国惠康基金; 芬兰科学院;
关键词
COST-EFFECTIVENESS ANALYSIS; STAGE BREAST-CANCER; HEALTH-CARE; PERSONALIZED MEDICINE; TRASTUZUMAB THERAPY; HORMONE-RECEPTOR; BARRIERS; WOMEN; ASSAY; IMPLEMENTATION;
D O I
10.1007/s40273-019-00801-9
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and Objective Precision (stratified or personalised) medicine is underpinned by the premise that it is feasible to identify known heterogeneity using a specific test or algorithm in patient populations and to use this information to guide patient care to improve health and well-being. This study aimed to understand if, and how, previous economic evaluations of precision medicine had taken account of the impact of capacity constraints. Methods A meta-review was conducted of published systematic reviews of economic evaluations of precision medicine (test-treat interventions) and individual studies included in these reviews. Due to the volume of studies identified, a sample of papers published from 2007 to 2015 was collated. A narrative analysis identified whether potential capacity constraints were discussed qualitatively in the studies and, if relevant, which quantitative methods were used to account for capacity constraints. Results A total of 45 systematic reviews of economic evaluations of precision medicine were identified, from which 222 studies focusing on test-treat interventions, published between 2007 and 2015, were extracted. Of these studies, 33 (15%) qualitatively discussed the potential impact of capacity constraints, including budget constraints; quality of tests and the testing process; ease of use of tests in clinical practice; and decision uncertainty. Quantitative methods (nine studies) to account for capacity constraints included static methods such as capturing inefficiencies in trials or models and sensitivity analysis around model parameters; and dynamic methods, which allow the impact of capacity constraints on cost effectiveness to change over time. Conclusions Understanding the cost effectiveness of precision medicine is necessary, but not sufficient, evidence for its successful implementation. There are currently few examples of evaluations that have quantified the impact of capacity constraints, which suggests an area of focus for future research.
引用
收藏
页码:1011 / 1027
页数:17
相关论文
共 50 条
  • [1] Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review
    Stuart J. Wright
    William G. Newman
    Katherine Payne
    [J]. PharmacoEconomics, 2019, 37 : 1011 - 1027
  • [2] ACCOUNTING FOR CAPACITY CONSTRAINTS IN ECONOMIC EVALUATIONS OF STRATIFIED MEDICINE: A SYSTEMATIC REVIEW
    Wright, S. J.
    Moore, H.
    Daker-White, G.
    Newman, W.
    Payne, K.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A738 - A739
  • [3] Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine
    Wright, Stuart J.
    Newman, William G.
    Payne, Katherine
    [J]. MEDICAL DECISION MAKING, 2022, 42 (04) : 538 - 553
  • [4] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS IN PERSONALIZED MEDICINE
    Lachaine, J.
    Bibeau, J.
    Mathurin, K.
    Miron, A.
    Beauchemin, C.
    Benmouhoub, I
    Bouchama, N.
    Castonguay, A.
    Charron, J.
    Enckle, G., I
    Lambert-Obry, V
    Lapierre, M.
    Piche-Richard, V
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A533 - A533
  • [5] A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine
    Patrick Fahr
    James Buchanan
    Sarah Wordsworth
    [J]. Applied Health Economics and Health Policy, 2019, 17 : 443 - 452
  • [6] A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine
    Fahr, Patrick
    Buchanan, James
    Wordsworth, Sarah
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2019, 17 (04) : 443 - 452
  • [7] Quality of health economic evaluations in emergency medicine journals: a systematic review
    Shawn Chhabra
    Austin Cameron
    Kednapa Thavorn
    Lindsey Sikora
    Krishan Yadav
    [J]. Canadian Journal of Emergency Medicine, 2023, 25 : 676 - 688
  • [8] Quality of health economic evaluations in emergency medicine journals: a systematic review
    Chhabra, Shawn
    Cameron, Austin
    Thavorn, Kednapa
    Sikora, Lindsey
    Yadav, Krishan
    [J]. CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2023, 25 (08) : 676 - 688
  • [9] A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials
    Nosrati, Marzieh
    Nikfar, Shekoufeh
    Hasanzad, Mandana
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (07) : 1061 - 1070
  • [10] The Patient in Precision Medicine: A Systematic Review Examining Evaluations of Patient-Facing Materials
    Wynn, Rachel M.
    Adams, Katharine T.
    Kowalski, Rebecca L.
    Shivega, Winnie G.
    Ratwani, Raj M.
    Miller, Kristen E.
    [J]. JOURNAL OF HEALTHCARE ENGINEERING, 2018, 2018